# OssiMend BA in Posterolateral Instrumented Lumbar Fusion

> **NCT04775537** · — · RECRUITING · sponsor: **Collagen Matrix** · enrollment: 120 (estimated)

## Conditions studied

- Spinal Disease
- Degenerative Disc Disease

## Interventions

- **DEVICE:** OssiMend™ Bioactive Moldable

## Key facts

- **NCT ID:** NCT04775537
- **Lead sponsor:** Collagen Matrix
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-21
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-01-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04775537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04775537, "OssiMend BA in Posterolateral Instrumented Lumbar Fusion". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04775537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*